FDA NDC Directory · JSON-LD · Markdown

Oxybutynin Chloride

NDC 54838-510 · HUMAN PRESCRIPTION DRUG · SYRUP

Labeler / ManufacturerLannett Company, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA074520
Dosage form / routeSYRUP · ORAL
Active ingredientsOXYBUTYNIN CHLORIDE (5 mg/5mL)
Marketing started19960329
Package count1

External sources

Source: openFDA. Public-domain (CC0).